7:30 am |
Breakfast, Non-CME Presentation & Registration
|
8:20 am |
Welcome & Introductions
|
Session 1 - Advances in basic and translational immunology for the clinical rheumatologist
|
8:30 am |
Immune profiling of patients with autoimmune diseases: defining metrics of immune dysregulation
Deepak Rao, MD, PhD |
9:00 am |
The evolution of immune effector cell therapies for the treatment of autoimmune diseases
Maximilian F. Konig, MD |
9:30 am |
Panel discussion
|
10:00 am |
Break & Exhibits
|
10:20 am |
IL-23 - Advances in basic and clinical immunology
Christopher Ritchlin, MD, MPH |
10:50 am |
New insights into the role of EBV in autoimmune diseases
William Robinson, MD, PhD |
11:20 am |
Panel discussion
|
11:50 am |
Lunch & Non-CME Presentations
|
Session 2 – Emerging Treatments in IMIDs
|
1:00 pm |
Signal and the Noise: Safety in Rheumatology
Michael Putman, MD, MSci |
1:25 pm |
PsA
Christopher Ritchlin, MD, MPH |
1:50 pm |
Clinical Insights discussion
M. Elaine Husni, MD, MPH; Anthony Fernandez, MD, PhD; Michael Putman, MD, MSCI; Christopher Ritchlin, MD, MPH |
2:20 pm |
Difficult to Treat RA (D2TRA)
Jack Cush, MD |
2:50 pm |
Clinical Insights discussion
Jack Cush, MD, and Len Calabrese, DO |
3:15 pm |
Break
|
3:35 pm |
Emerging treatments on Lupus nephritis
Michelle Petri, MD, MPH |
4:05 pm |
Advances in the treatment of inflammatory myopathies
Rohit Aggarwal, MD, MS |
4:35 pm |
Clinical Insights Discussion
Rohit Aggarwal, MD, MS; Len Calabrese, DO; Emily Littlejohn, DO; Michelle Petri, MD, MPH |
5:05 pm |
Adjourn to Reception and Poster Session (non-CME)
|